Organic compounds -- part of the class 532-570 series inventions 09/08

20080234472 - Sucralose production method: immediately before the removal of the reaction vehicle, the reaction stream is subjected to a precipitation step comprising treatment with a metal or ammonium hydroxide and carbon dioxide to form a precipitate of the corresponding metal or ammonium carbonate in which at least a portion of said high molecular weight... Agent: Ratnerprestia

20080234473 - Oligonucleotides for amplifying trichomonas vaginalis-derived nucleic acid: Oligonucleotides useful for determining the presence of Trichomonas vaginalis in a test sample. The oligonucleotides may be incorporated into detection probes, helper probes, capture probes and amplification oligonucleotides, and used in various combinations thereof.... Agent: Gen Probe Incorporated

20080234474 - Methods for the separation of biological molecules using sulfolane: The present invention provides a method for the isolation of biological molecules by the adsorption of the molecules onto a mineral substrate in the presence of an appropriate mixture of salts and sufolane. Preferably, the biological molecules are nucleic acids. Compositions and kits for performing the process according to the... Agent: Agilent Techologies Inc

20080234475 - Process for the synthesis of 2'-o-substituted purines: The present invention provides an improved process for the synthesis of 2′-O-substituted purine nucleosides. The process includes anhydro or thioanhydro ring opening of a selected 8,2′-cyclopurine nucleoside with a weak nucleophile in the presence of a Lewis acid ester, followed by reduction to afford the desired 2′-O-substituted purine nucleoside.... Agent: Isis Pharmaceuticals Inc

20080234476 - Polysaccharide derivatives and structures employing same: Polysaccharide derivatives, more particularly heteropolysaccharide derivatives, especially hemicellulose derivatives, methods for making same and structures employing same are provided.... Agent: The Procter & Gamble Company Global Legal Department - Ip

20080234477 - Method for preparing chitosan nano-particles: This invention involves a new method for preparing chitosan nano-particles. This method uses the nano-cavity technology so as to obtain pure chitosan nano-particles and pure chitosan nano-particle latex in a simple way.... Agent: The Hong Kong Polytechnic University Suite 600

20080227963 - Process for preparing glycopeptide phosphonate derivatives: Disclosed are processes for preparing glycopeptide phosphonate derivatives having an amino-containing side chain. Several of the process steps are conducted in a single reaction vessel without isolation of intermediate reaction products, thereby generating less waste and improving the overall efficiency and yield of the process.... Agent: Theravance, Inc.

20080227964 - 2'-silyl containing thiocarbonate protecting groups for rna synthesis: Nucleoside monomers, nucleic acids, e.g., oligonucleotides and polynucleotides, methods of making each, methods of deprotecting each, and the like are disclosed herein. Aspects of the invention include 2′ silyl containing thiocarbonate protecting groups. Corresponding compositions and methods are provided.... Agent: Agilent Technologies Inc.

20080227965 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers: The present invention provides for purified or highly pure recombinant monoclonal antibodies that bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), along with nucleic acid sequences encoding the antibody chains, and the amino acid sequences corresponding to said nucleic acids and uses for said sequences.... Agent: Nixon Peabody, LLP

20080227966 - Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases: Genes encoding Class II EPSPS enzymes are disclosed. The genes are useful in producing transformed bacteria and plants which are tolerant to glyphosate herbicide. Class II EPSPS genes share little homology with known, Class I EPSPS genes, and do not hybridize to probes from Class I EPSPS's. The Class II... Agent: Howrey LLP

20080227967 - Sirna targeting ribonucleotide reductase m2 polypeptide (rrm2 or rnr-r2): Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed... Agent: Kalow & Springut LLP

20080227968 - Oligonucleotide probe: f

20080227969 - Nucleic acid adsorbent; methods for adsorbing, removing, dissociating, and recovering nucleic acids using the same; and method for regenerating the same: wherein R1 represents hydrogen, fluoride, or methyl; R2 and R3 each independently represent alkyl of 1 to 6 carbon atoms; A is —NH— or —O—; and B represents alkylene of 2 to 18 carbon atoms. Nucleic acids are recovered from cell extract by allowing them to be adsorbed to the... Agent: Finnegan, Henderson, Farabow, Garrett & Dunner LLP

20080227970 - Methods and compositions for sequencing a nucleic acid: The invention provides a family of tethered nucleotide analogs useful in sequencing nucleic acids containing a homopolymer region comprising, for example, two or more base repeats, and to sequencing methods using such tethered nucleotide analogs.... Agent: Cooley Godward Kronish LLP Attn: Patent Group

20080227971 - Deacylation of sucralose-6-acylates: A method of making sucralose includes maintaining a solution of a sucralose-6-acylate in an aqueous solvent at a temperature in a range from −20° C. to 20° C. and at a pH of at least 12.2 and less than 14.0 for a period of time sufficient to deacylate substantially all... Agent: Ratnerprestia

20080227972 - Decomposition method of cellulose and production method of glucose: A method for decomposing cellulose to be contained in a cellulose raw material is provided. A pulverized cellulose based biomass is enclosed in a pressure closed vessel, and a sodium hydroxide aqueous solution having a concentration of 5%, pure water and 5 g of nickel oxyhydroxide obtained by solid-solving therein... Agent: Bruce L. Adams, Esq Adams & Wilks

20080221312 - Method for crystallizing sucralose: The present application discloses a method for crystallizing sucralose, which uses an alcohol solvent or a mixed solvent of alcohol and other solvent(s) in the crystallization of sucralose.... Agent: Occhiuti Rohlicek & Tsao, LLP

20080221313 - Process for the preparation of sucralose by the deacylation of trichlorosucrose-6-ethyl ester: The present invention discloses a process for the preparation of sucralose by the deacylation of trichlorosucrose-6-ethyl ester, wherein the deacylation reaction is performed in an alcohol solvent in the presence of organic base catalyst, so as to obtain sucralose.... Agent: Occhiuti Rohlicek & Tsao, LLP

20080221314 - Heteromolecular metal-humic (chelate) complexes: where A is one or several humic complexes which may be totally or partially sulfonated or may have been treated with an amine in order to protect the carboxylic groups from interacting with polyvalent cations, and B is a non-humic complexing (organic chelating agent) compound, the biological and chemical stability... Agent: Law Office Of John C. Mcmahon

20080221315 - Nucleic acid-based translation system and method for decoding nucleic acid encrypted message: A nucleic acid-based translation system where the components of a nucleic acid multicrossover molecule serve as message, translation device and part of the translated product. One continuous strand of a nucleic acid multicrossover molecule acts as a message, which nucleic acid crossover strands, functioning together as a translation device, translate... Agent: Browdy And Neimark, P.l.l.c. 624 Ninth Street, Nw

20080221316 - Sirna targeting ethanolamine kinase i1 (eki1): Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed... Agent: Kalow & Springut LLP

20080221317 - Sirna targeting cystic fibrosis transmembrane conductance regulator (cftr): Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed... Agent: Kalow & Springut LLP

20080221318 - Cellulose- or lignocellulose-containing composite materials based on a silane-based composite as a binder: The present invention relates to a composite material based on (a) a cellulose- or lignocellulose-containing material and (b) a composite as a binder, the composite resulting from the reaction of at least the components (i) a glycidyloxypropylalkoxysilane, (ii) an aqueous silica sol having a solids content of >20% by weight,... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.c.

20080214798 - Sugar chain asparagine derivatives, sugar chain asparagine, sugar chain and processes for producing these: An asparagine-linked α2,3-oligosaccharide having undeca- to hepta-saccharides, an asparagine-linked α2,6-oligosaccharide having undeca- to hepta-saccharides and containing fluorine and an asparagine-linked oligosaccharide derivative containing at least one fucose in N-acetylglucosamine on the nonreducing terminal side of an asparagine-linked oligosaccharide wherein the asparagine has amino group protected with a lipophilic protective group,... Agent: Kubovcik & Kubovcik

20080214799 - Biosynthetic platform for cardioprotective stress response in human fatal heart tissue: The present invention is directed toward elucidation of a human fetal gene expression program in response to simulated ischemia/reperfusion (I/R) in order to identify molecular targets which account for the innate cardioprotection exhibited by the fetal phenotype.... Agent: Mchale & Slavin, P.A.

20080214800 - Sirt inhibitors that bind to nad: Methods of treating sirtuin related disorders and compounds useful in treating sirtuin related disorders are described.... Agent: Fish & Richardson PC

20080214801 - Chemoselective ligation: The present invention features a chemoselective ligation reaction that can be carried out under physiological conditions. In general, the invention involves condensation of a specifically engineered phosphine, which can provide for formation of an amide bond between the two reactive partners resulting in a final product comprising a phosphine moiety,... Agent: Bozicevic, Field & Francis LLP

20080214802 - Substituted liposaccharides useful in the treatment and prevention of endotoxemia: Novel substituted liposaccharides useful as in the prophylactic and affirmative treatment of endotoxemia including sepsis, septicemia and various forms of septic shock and methods of using these agents are provided. Also provided are methods of preparing these agents and intermediates useful therein.... Agent: Clark & Elbing LLP

20080214803 - Production of glucosamine from plant species: The present invention relates to a process for generating glucosamine from plants wherein fresh plant materials, or re-hydrated dried plant materials or plant extracts, are heated at a temperature comprised between 70 and 110° C. for more than hours, characterized in that a fertilizer acting as glucosamine precursor is added... Agent: Bell, Boyd & Lloyd LLP

20080214804 - Thermal conduction during alkaline extraction: The present invention relates to an improved process for extracting and subsequently isolating components from biological material, in particular sugar beets.... Agent: Ostrolenk Faber Gerb & Soffen